Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial
Top Cited Papers
- 7 July 2022
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 400 (10346) , 116-125
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic StrokeNew England Journal of Medicine, 2016
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trialsThe Lancet, 2016
- Younger Stroke Patients With Large Pretreatment Diffusion-Weighted Imaging Lesions May Benefit From Endovascular TreatmentStroke, 2015
- Thrombectomy within 8 Hours after Symptom Onset in Ischemic StrokeNew England Journal of Medicine, 2015
- Randomized Assessment of Rapid Endovascular Treatment of Ischemic StrokeNew England Journal of Medicine, 2015
- Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging SelectionNew England Journal of Medicine, 2015
- A Randomized Trial of Intraarterial Treatment for Acute Ischemic StrokeNew England Journal of Medicine, 2015
- Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsThe Lancet, 2014
- Race/Ethnic Differences in the Risk of Hemorrhagic Complications Among Patients With Ischemic Stroke Receiving Thrombolytic TherapyStroke, 2014
- Improving the Efficiency of Stroke TrialsStroke, 2013